Boothbay Fund Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $542K | Sell |
20,962
-7,887
| -27% | -$204K | 0.01% | 703 |
|
|
2025
Q1 | $294K | Sell |
28,849
-8,209
| -22% | -$83.7K | 0.01% | 908 |
|
|
2024
Q4 | $517K | Buy |
37,058
+13,793
| +59% | +$192K | 0.01% | 722 |
|
|
2024
Q3 | $454K | Hold |
23,265
| – | – | 0.01% | 860 |
|
|
2024
Q2 | $433K | Buy |
+23,265
| New | +$433K | 0.01% | 903 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2090 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1903 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1858 |
|
|
2021
Q1 | – | Sell |
-726
| Closed | -$185K | – | 1484 |
|
|
2020
Q4 | $185K | Buy |
+726
| New | +$185K | 0.01% | 949 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1041 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 943 |
|
|
2020
Q1 | – | Sell |
-2,435
| Closed | -$788K | – | 891 |
|
|
2019
Q4 | $788K | Buy |
2,435
+1,484
| +156% | +$480K | 0.07% | 316 |
|
|
2019
Q3 | $260K | Buy |
951
+155
| +19% | +$42.4K | 0.02% | 516 |
|
|
2019
Q2 | $425K | Buy |
+796
| New | +$425K | 0.04% | 370 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 719 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 775 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 734 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 642 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 697 |
|